MediBuddy, India's largest digital healthcare platform, has achieved significant progress towards EBITDA neutrality, nearing break-even with a marginal loss at the end of the previous fiscal year (FY 23-24). This milestone reinforces MediBuddy's position as India's fastest-growing digital healthcare company, driven by its wide-ranging service offerings and steadfast commitment to revolutionizing healthcare accessibility across the nation.

Over the past three years, MediBuddy has experienced an impressive 2.4X growth in its user base, serving nearly 3 crore Indians, including over 1 crore subscribers. The company is now focused on exploring merger and acquisition (M&A) opportunities in key healthcare sectors such as chronic disease management, mental health, diabetes, women's care, and weight management. This initiative is supported by an $18 million capital pool dedicated to these investments.

Satish Kannan, Co-founder and CEO of MediBuddy, stated, "MediBuddy is spearheading a healthcare revolution in India by prioritizing customer-centric, technology-driven solutions. We empower doctors through our platform, offering accessible care via video consultations, hospital visits, clinics, pharmacy deliveries, and diagnostic services. Leveraging technology, our platform enhances doctor-patient interactions, driving our remarkable growth and expanding healthcare access nationwide."

Following the successful integration of vHealth, a recent acquisition made in 2023, MediBuddy has significantly expanded its reach, particularly in tier two and tier three areas, allowing the platform to serve a broader customer base. With a rapidly growing network of over 90,000+ doctors across 22+ specialties, 7,100+ hospitals and clinics, 5,000+ diagnostic centers, and 2,500+ pharmacies, MediBuddy has established itself as a comprehensive healthcare solution provider. Additionally, to enhance its diagnostic capabilities and service offerings further, MediBuddy has onboarded over 10,000+ hospitals and diagnostic centers for all radiology and pathology investigations.

These impressive achievements lay the foundation for continued growth in the future, highlighting MediBuddy's ambition to expand its market share in the rapidly evolving digital healthcare industry.